Petersen, D. L., Krejsgaard, T., Berthelsen, J., Fredholm, S., Willerslev-Olsen, A., Sibbesen, N. A., . . . Odum, N. (2014). B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL). Nature Publishing Group.
Chicago Style CitationPetersen, D L., et al. B-lymphoid Tyrosine Kinase (Blk) Is an Oncogene and a Potential Target for Therapy With Dasatinib in Cutaneous T-cell Lymphoma (CTCL). Nature Publishing Group, 2014.
MLA CitationPetersen, D L., et al. B-lymphoid Tyrosine Kinase (Blk) Is an Oncogene and a Potential Target for Therapy With Dasatinib in Cutaneous T-cell Lymphoma (CTCL). Nature Publishing Group, 2014.
Warning: These citations may not always be 100% accurate.